In order to modify exon 27 splicing, we used splice-site ASOs, which have previously been used to modify splicing in the dystrophin gene [11-13] and to correct the aberrant alternative splicing in the ß-thalassemia mutation IVS2-654 [14]. Here, DMD is linked to thalassemia.